5-year stem cell safety study for rare eye disease
NCT ID NCT05786287
First seen Feb 28, 2026 · Last updated May 21, 2026 · Updated 10 times
Summary
This study follows 18 people with retinitis pigmentosa who received umbilical cord stem cell treatment 5 years ago. Researchers will check vision, eye structure, and overall safety. The goal is to see if the treatment remains safe over the long term, not to test new benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jakarta Eye Center Hospital
Jakarta, DKI Jakarta, Indonesia
-
Sardjito Hospital
Yogyakarta, Special Region, 55284, Indonesia
Conditions
Explore the condition pages connected to this study.